Latest / The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It / 658. GLP-1s Beyond Weight Loss: Can They Heal Your Gut and Lower Inflammation
Transcript
- 0:00The pros outweigh the cons for me right now in this moment.
- 0:05So I'm not anti-GLP.
- 0:07I'm more pro-GLP.
- 0:09But I think we have to get our heads out of the sand because a lot of people are in the sand.
- 0:15A lot of people's heads are in the sand.
- 0:18I just want to say thank you.
- 0:20The fact that you're here means that you have trusted me with something so valuable these days, your time.
- 0:27And I do not take that lightly at all.
- 0:30So if you're listening because you're exhausted, you're gaining weight for no reason, losing your hair, getting really frustrated, or you've been told that everything looks normal, when you know deep down something isn't right, I want you to know that I see you.
- 0:45I've been where you are.
- 0:46And that's exactly why I created this podcast.
- 0:49My mission is super simple, to give you the information, the hope and the tools that I wish someone had given me years ago.
- 0:57So my goal is you get to stop wondering what's wrong with your body and finally start getting your life back.
- 1:05So if these episodes have helped you at all, would you do me one small favor?
- 1:10Take just a few seconds to follow the show, the little button in the upper corner, and then leave a review.
- 1:17Every follow and every review helps this podcast reach another person who's lying there awake at night wondering why they don't even recognize themselves anymore when they look in the mirror.
- 1:28Wondering what's happened to this amazing, energized, full of life person they used to be.
- 1:33You're helping them.
- 1:34And not only that,
- 1:36When you follow the show, you'll be notified about the hottest episodes everyone is listening to and everyone's downloading, along with any bonus episodes I drop throughout the month.
- 1:46Think of it as your insider pass.
- 1:48So thank you for letting me be part of your journey.
- 1:51And thank you for your time.
- 1:52Now, let's get into today's episode.
- 1:54So.
- 1:58I had to record this episode because about two weeks ago, I felt so incredibly bloated.
- 2:06It's like my stomach was distended, pushing outward, pushing on the sides.
- 2:11I felt like I lost my waistline because I was so bloated.
- 2:15Do you hear me?
- 2:16Are you nodding your head in agreement?
- 2:18Is this resonating with you?
- 2:19I know so many of you deal with bloating on a pretty consistent basis.
- 2:25And so now I can honestly say, wow, that was just miserable.
- 2:29I didn't know what to do about it.
- 2:31I tried digestive enzymes.
- 2:32I tried probiotics.
- 2:35Nothing was really working.
- 2:36I was questioning, all right, wait, maybe it's my estrogen.
- 2:38Maybe I need more estrogen because as we know, as our estrogen drops, ladies, we get more bloated.
- 2:45What about thyroid?
- 2:46Well, I know my thyroid's optimized.
- 2:48What is happening?
- 2:49What?
- 2:49So I thought about it for a moment.
- 2:52I was like, you know what?
- 2:53Here's the thing.
- 2:54Here's what I've been doing.
- 2:55And I talk about GLPs all the time.
- 2:57And I have to always make this disclaimer.
- 2:59I'm not anti-GLP.
- 3:00In fact, today's episode is pro-GLP with a story I'm about to share.
- 3:05I will always give you both sides of the fence, both sides of the argument.
- 3:11I'm never going to BS you.
- 3:12I will never lie to you.
- 3:13I will never try to sell you something because it benefits me.
- 3:17I have no dog in this race whatsoever with GLPs.
- 3:21You know, you might listen to other podcasts where the influencer or you're looking on IG and you're seeing all of these IG influencers just, yay, GLP.
- 3:30GLPs are great.
- 3:31Oh, by the way, we sell them too.
- 3:34And we have a program with GLPs.
- 3:36Okay, I get that.
- 3:37I get that.
- 3:39But we don't.
- 3:39Like, we'll prescribe GLPs in our practice all day long.
- 3:42Absolutely.
- 3:43But I'm not out there promoting something that is GLP-based.
- 3:48So I want you to know that I don't have a dog in this race at all.
- 3:52I'm just bringing you information.
- 3:54So here's the anecdotal, and then I'm going to get into the scientific.
- 3:57I thought to myself, well, wait a minute.
- 3:59So I have been trying Reda True Tie, because all we all have heard about this left and right, right?
- 4:04About Reda, Reda, Reda.
- 4:06You got TikTok influencers.
- 4:09And this is where I have a problem with GLPs.
- 4:11You got TikTok influencers pushing Reda True Tide with their affiliate link to the research-only website.
- 4:17So, you know, I got some reputable Reda when it was available on Jay Campbell's site.
- 4:23Now it's not because he's actually following the rules on, like, a lot of these research sites.
- 4:27We don't even know if what you're getting is Reda.
- 4:30So I tried it.
- 4:30You know what?
- 4:30I got to tell you, I don't like it.
- 4:32It really does nothing for me.
- 4:34The one time that I accidentally overdosed that I had two weeks of hell.
- 4:37So I'm not really a big fan of RETA.
- 4:39So I had done RETA for the last, I don't know, two, three weeks, whatever.
- 4:43And then I thought, maybe it's that.
- 4:45So I had some trisepatide left.
- 4:46So I'm like, I'm going to go back to microdosing my trisepatide.
- 4:50And it's like I took a small shot.
- 4:53It was like one milligram, maybe.
- 4:55Yeah.
- 4:56And immediately my distension went down.
- 4:59I felt so much better, like within a day.
- 5:03So that really showed me that there are some tremendous benefits with GLPs in the gut.
- 5:11And ironically, I was getting my hair done.
- 5:12I'm talking to my hairdresser about it.
- 5:13She's like, I know that happened to me too.
- 5:16So anecdotally, we're hearing a lot of GI improvement.
- 5:22with microdosing GLPs.
- 5:23Now, as I always, always, always say, the cure versus the poison is in the dose.
- 5:30You know, classic cliche saying, but yet it's so, so, so true when it comes to these GLPs.
- 5:36And that's where the pros and the cons are.
- 5:38You get a lot more pros when you can keep your dose low, a lot more cons as you increase your dose and go into the standard dosing or go into the protocols that a lot of these online GLP places will do.
- 5:55What they do is they just continuously increase your dose.
- 5:58If you keep your dose as low as possible where it's working for you, but you're not getting the side effects, that really is the sweet spot.
- 6:05And I will say that over and over and over again.
- 6:07That's where you get the benefits without the side effects that we know about.
- 6:12Now, you've also heard me say, because this is just true.
- 6:16We don't know the long term.
- 6:17We don't know the long term, but I'm still taking it.
- 6:19So I'll be honest with you.
- 6:20I don't know the long term.
- 6:21We don't know what it's going to do.
- 6:23We don't have the studies because it hasn't been out that long.
- 6:26But I'm still taking it.
- 6:28The pros outweigh the cons for me right now in this moment.
- 6:32So I'm not anti-GLP.
- 6:35I'm more pro-GLP.
- 6:36But I think we have to get our heads out of the sand because a lot of people are in the sand.
- 6:42A lot of people's heads are in the sand.
- 6:44I'm sorry, I know this is a little tangent and I'll get to the actual meat of this episode in a moment.
- 6:49But I don't know if you've ever checked out.
- 6:51Go look at my YouTube.
- 6:53Go to YouTube.
- 6:54While you're there, subscribe.
- 6:55Thank you.
- 6:56But go to YouTube, subscribe, follow.
- 6:59And then look for a couple of the videos that I did that are not anti-GLP.
- 7:04They're just showing the other side for goodness sake.
- 7:06The people that want to keep their head in the sand, like I say this all the time, if you say anything negative about a GLP to these hardcore diehard fans, it's like you killed their dog.
- 7:17Like they come at you with guns blazing.
- 7:21So the comments are hysterical.
- 7:24I mean, they're just, go look at them.
- 7:26These people are cray cray, like off their rockers because they're literally addicted to their GLP.
- 7:35So you can't say anything negative about a GLP to someone that's addicted to it.
- 7:39It's like saying something negative about alcohol to an alcoholic.
- 7:42Like they're going to take your head off and give you all the reasons why alcohol is beneficial.
- 7:46It's the same thing.
- 7:47Like, let's just be honest, okay?
- 7:49Okay.
- 7:50So today, anywho, today, that's just for your entertainment.
- 7:52Today, we're actually going to be going into some more pros on the GLP.
- 7:58Can they actually heal your gut?
- 7:59So here's what we know about GLPs, right?
- 8:02We know they turn down food noise.
- 8:03We know they reduce appetite.
- 8:05We know they help people feel fuller, faster, which reduces your food consumption.
- 8:10They help to lower blood sugar.
- 8:12We see improvements in A1C.
- 8:14They're lowering insulin.
- 8:15Of course, people are losing weight from them.
- 8:18However, they're also influencing a lot of other factors in the body, like systemic inflammation, immune signaling, the intestinal barrier, gut bacteria, bile acid metabolism, intestinal motility,
- 8:34and the communication between the gut and the brain.
- 8:38So we now have legitimate evidence, legitimate evidence showing that certain GLPs, and this one in particular was done on semaglutide, like the OG GLP,
- 8:50Legitimate evidence showing that semaglutin can lower C-reactive protein, which is a marker of systemic inflammation.
- 8:58And we're seeing it reduced by 40 to 50% when compared with a placebo.
- 9:04So that's huge.
- 9:0740 to 50% reduction in inflammation and CRP values is ginormous.
- 9:12When we're talking about impact on systemic inflammation, which is so pervasive in our human population these days with the society and the world that we live in, we have observational studies suggesting that people with inflammatory bowel disease or IBD who take a GLP may experience fewer hospitalizations and surgeries.
- 9:32And for those who don't know what IBD is, it's pretty rough.
- 9:36IBS is kind of like a baby version of IBD, almost like a precursor.
- 9:41IBD can come with a lot of complications.
- 9:44And yes, hospitalization, sometimes surgeries, sometimes dissecting the bowel, reducing the colon.
- 9:50Colostomy bags are very popular with IBDs and nobody wants that.
- 9:55So if we can bring in a GLP medication, I'm going to be able to do that.
- 9:58to help reduce the amount of hospitalizations and surgeries of people with IBD.
- 10:02Oh my God, that's a game changer.
- 10:04That's a life changer, a true life changer.
- 10:08And we have early evidence that these medications may alter organisms such as acromantia.
- 10:15Acromantia is one of the bacteria associated with intestinal barrier integrity, but it's also tied to our metabolic health.
- 10:23Acromantia is something that we can actually test on a GI map and we can see how much you have.
- 10:29Are you low in acromantia?
- 10:31When we see low acromantia, we see that correlated with insulin resistance and metabolic dysfunction.
- 10:37So there's that direct correlation there where GLPs can come in and actually help to alter that gut bacteria and increase acromantia in the gut.
- 10:46Okay.
- 10:47But then we have this major contradiction.
- 10:49How can a medication potentially reduce inflammation and support the intestinal barrier while also causing nausea, constipation, acid reflux, vomiting, bloating, delayed gastric emptying, or gastroparesis?
- 11:06This is what we're going to unpack today.
- 11:08So the question is not simply, are GLPs good or bad for the gut?
- 11:12The question is, which parts of gut health might improve, which people may benefit, and which existing gut problems could become significantly worse?
- 11:25Okay, so we have to view GLP-1s as metabolic tools.
- 11:31They need to be used in the right patient, at the right dose.
- 11:34And that's where we see that they have benefits that go well beyond weight loss, well beyond.
- 11:40They don't replace thyroid optimization, hormone optimization, proper food, protein, strength training, hydration.
- 11:47I mean, we know that these GLPs won't even work if your thyroid and your hormones are in the toilet.
- 11:53even on the gut.
- 11:54So if your thyroid is low and slow and you take a GLP, number one, you're not getting any weight loss.
- 11:59You're not getting any A1C benefit.
- 12:01You're burning your money, but you're also going to compound your already slow gastric motility from a low and slow thyroid.
- 12:09And now you're adding on this medication that's going to slow things down even further.
- 12:13You could experience compounded symptoms, worsening symptoms instead of the
- 12:22I can't say that enough.
- 12:23And I wish more of these IG influencers that were pushing GLPs would talk more about that, but that's not in their financial best interest.
- 12:31They just want you to come to their clinic and buy the GLPs without doing anything else.
- 12:35And they really don't care if you get frustrated and waste your money because they're taking your money.
- 12:39And they're just going to tell you to increase the dose.
- 12:41I'm going to tell you to fix your thyroid and your hormones first, save your money, then bring in the GLP for all of the benefits, including extra weight loss, inflammation reduction, and what we're going to talk about today, the gut and everything works together.
- 12:53And you get to save money instead of burning it every single month where your thyroid and hormones are in the toilet, but you're still spending it on GLPs.
- 13:01Okay, so what does GLP do?
- 13:03GLP, we're going to talk about GLP ones.
- 13:06GLP-1 stands for glucagon-like peptide 1.
- 13:09Now, GLP-1 is technically the semaglutides.
- 13:14GLP-2, which is a GLP-GIP, is terzepatide.
- 13:19And then GLP-3 is your retitrutide.
- 13:21That is an FDA-approved, not on the market, so I'm taking it off of this conversation.
- 13:25Although it does kind of play a role.
- 13:26I mean, anytime we talk about GLPs in general, yes, we can bring in Retta.
- 13:31If Retta's working for you, keep using it.
- 13:33It's cool.
- 13:34It's fine.
- 13:34It's fine.
- 13:35I don't know because the studies haven't been done on Reda and all of the benefits that I'm going to talk about today.
- 13:42We can assume that if the benefits show with truzevitide, they're going to show with Reda trutide as well.
- 13:49But we don't know for sure.
- 13:50So that's just going to be an assumption.
- 13:53So when we're looking at GLPs or GLP-1s, glucone-like peptide one, it's a hormone produced primarily by specialized cells in the intestine.
- 14:03That's where GLP is produced, in your intestine.
- 14:06And these cells are called L cells.
- 14:08So these cells are found primarily toward the end of the small intestine and in the colon.
- 14:14So when we eat, nutrients enter the digestive tract and they stimulate the release of GLP-1.
- 14:21GLP-1 then carries information from the digestive tract to other parts of the body, including the pancreas, the brain, and this is where your gut is talking, talking to your body, pancreas, brain, stomach, liver, nervous system, cardiovascular system, immune system.
- 14:38This is why calling GLP-1 simply an appetite hormone does not
- 14:42do it justice.
- 14:43It does so much more.
- 14:45So after a meal, natural GLP that's produced by your gut helps with increasing insulin secretion from the pancreas.
- 14:55This is where it's signaling the pancreas.
- 14:57It helps increase insulin secretion from the pancreas when blood glucose is elevated.
- 15:02I mean, that's what we want to have happen.
- 15:04We don't want to suppress our insulin.
- 15:06Insulin is a
- 15:09We don't want too much of it.
- 15:10We want it in that sweet spot.
- 15:12So it increases insulin secretion to lower blood glucose.
- 15:15It decreases inappropriate glucagon secretion.
- 15:20It reduces post-meal blood sugar spikes.
- 15:23So this is where we see that improvement in our blood glucose markers.
- 15:27It slows the rate at which food leaves the stomach.
- 15:30So this is where people are feeling fuller faster, but this is also where we're getting the acid reflux and the bloating and the slow gastric mortality.
- 15:37So that's good and bad.
- 15:39Increasing satiety, this is both from the food being in your gut and also from triggering the brain and the brain's hunger signals that's calming those down, reducing appetite.
- 15:50And it's communicating with the brain through these hormonal and neural pathways.
- 15:55So it's that gut-brain connection, again, coming into play.
- 15:59They coordinate the speed of digestion with the arrival of nutrients and potentially regulate immune and intestinal barrier activity.
- 16:08So this is all natural GLP-1.
- 16:10So natural GLPs, they don't actually remain active for very long.
- 16:14It's very, very quick.
- 16:16The body breaks it down rapidly.
- 16:19So this isn't something our, when our body naturally produces GLP-1s, it's not there for seven days.
- 16:24I know you're doing a shot once every seven days, natural GLP-1 in and out of your body very, very quickly.
- 16:30I mean, we're talking minutes, not days, minutes.
- 16:34So GLP-1 medications, they are engineered to resist that breakdown in our gut, which rapidly decreases the action and the potential benefits of the GLP.
- 16:46So GLP-1 medications are literally engineered to resist that breakdown, and they create a much stronger, much more longer-lasting GLP signal.
- 16:55And that stronger signal is part of why they work so well, and they work over the course of a week.
- 17:00That's why you only do it once a week.
- 17:02Your shot is only once a week.
- 17:04Now, why the gut response differs from person to person.
- 17:07So a person with very rapid digestion, high blood sugar, insulin resistance, frequent diarrhea, they may experience the slowing and metabolic effects as beneficial.
- 17:22Like, hey, this is amazing.
- 17:23I'm not processing my food so quickly.
- 17:25I'm not seeing those high blood sugar spikes on my CGM.
- 17:30I'm not going to the bathroom all the time.
- 17:31That's a win in and of itself.
- 17:33Right.
- 17:34A person with hypothyroidism and chronic constipation and already slowed gastric emptying may experience the same medication as nausea, reflux, constipation, abdominal distension, or food remaining in the stomach too long.
- 17:50And this is exactly what I said about this is why you can't take it.
- 17:53If you have non-optimized thyroid function, if you're still in that hypothyroid state, listen, I don't care if you're diagnosed with hypothyroidism or Hashimoto's and you're actually addressing it and getting it optimized the correct way, then we can't say, oh, you're hypothyroid.
- 18:08No, you're really not.
- 18:09You're normal now because you're optimized.
- 18:11But if you're walking around on T4 only, you're not optimized, you're working with a doctor who doesn't know what they're
- 18:16thyroid and that's on you.
- 18:18Don't use a GLP because you're going to be wasting your money, but you're also going to experience all of these additional side effects like the nausea reflux constipation because you haven't addressed your thyroid function.
- 18:29Now, these medications are not necessarily interchangeable.
- 18:35I mean, we already know that semaglutide being the first, being the
- 18:46And then, oh my gosh, I guess we could really say the OOGs, Liraglutide, Invictosa, Saxenda.
- 18:53I mean, we don't even hear those terms anymore because that's kind of been thrown out.
- 18:57That's a GLP-1 receptor agnus, but it's shorter acting.
- 19:00And now you have to administer daily.
- 19:02No one wants to give them a shot daily.
- 19:03So that's why the introduction of the once-a-week shots like Ozepic, like now Terzepatine found in Manjaro and ZepBound,
- 19:13So much better, so easier to use once a week instead of every single day.
- 19:18Now, terizepatide, GLP-2, that activates both GLP-1 receptors and GIP receptors.
- 19:26So therefore, when someone reports that terizepatide improved their inflammation, we can't automatically attribute the entire effect to GLP-1 because GIP signaling may contribute as well.
- 19:37Remember, terizepatide is GLP and GIP.
- 19:40Now, these drugs also differ in how long they act and how they affect appetite, gastric emptying, and tolerability.
- 19:48So that matters because some of the gut studies that we are discussing using liraglutide, the OOG, or an experimental GLP-1 analog, not semaglutide or trasebitide, will kind of skew what you may experience.
- 20:05But still, let's unpack it.
- 20:07Because when we see a benefit in one GLP study, even if it's the OG or the OOG version, we can still extract that and apply it to, we'll say, the new kids on the block like Trisabatina and Retta.
- 20:22Okay, let's dive in to the data.
- 20:25This is the strongest human evidence we have outside of anecdotal evidence, which you may have a story anecdotally just like mine on the bloating.
- 20:35That's awesome.
- 20:36Anecdotal evidence is so important.
- 20:39So let's stack that anecdotal evidence with the documented trials, human evidence.
- 20:44So the STEP trials.
- 20:46The STEP program was a collection of large phase three trials evaluating the once weekly semaglutide at 2.4 milligrams for weight management.
- 20:59Now, that would be a little bit of a higher dose for SEMA.
- 21:02Well, it would be a standard dose.
- 21:042.4 milligrams of SEMA would not be considered a microdose.
- 21:09However, if you move it over to TERS-appatide, 2.5 milligrams could be a microdose for someone.
- 21:16So could one.
- 21:17So could 0.5.
- 21:19So when we're talking microdosing, it really is unique and individual to the person, but then we also have to extrapolate it and apply it to whichever GLP we're talking about and look at the dosing for that GLP.
- 21:30So the STEP program, use semaglutide at a standard dose.
- 21:35Then they analyzed C-reactive proteins.
- 21:37So this is the CRP analysis.
- 21:40And these were all, again, randomized trials, double-blind, placebo-controlled.
- 21:44It was like the Mac daddy of any kind of scientific research you can do is going to be a double-blind, placebo-controlled, RCT, randomized-controlled trial.
- 21:56So that means the participants were randomly assigned to treatment.
- 21:59So neither the participants nor the investigators knew who was receiving the semaglutide versus the placebo.
- 22:07And the researchers followed them for more than a year.
- 22:09So we have a lot of data.
- 22:11That's fantastic.
- 22:12When the data is looked at over the course of time, it's always better than looked at in the course of a month or two.
- 22:18So step one.
- 22:20Step one included approximately 2,000 adults with obesity who didn't have type 2 diabetes.
- 22:28So all of them were overweight or obese.
- 22:29They did not have type 2 diabetes, which is in and of itself amazing.
- 22:33I don't know what standards they're using to actually diagnose type 2 diabetes.
- 22:39I'm going to assume it's just going by the A1C value of 5.6 or 5.7 and above.
- 22:44Now, you know, in functional medicine, we want your A1C down to 5.2 or less.
- 22:49So we would call you diabetic at a 5.5 or 5.6.
- 22:52They might not.
- 22:54Neither here nor there.
- 22:55Participants received either semaglutide at 2.4 milligrams or a placebo, along with lifestyle recommendations.
- 23:03So at 68 weeks, the average weight loss was approximately 14.9% loss, body fat loss, with SEMA 2.4 with placebo.
- 23:14So we know the weight loss is there.
- 23:15In the CRP analysis, semaglutide produced an estimated 44% greater reduction
- 23:22in CRP than placebo.
- 23:24So that comes back to what I said in the beginning, 40 to 50% reduction in inflammation.
- 23:28That's huge.
- 23:29That is huge.
- 23:31Okay.
- 23:32In the STEP trials, we have a step one, we have a step two, we have step three, we have step four.
- 23:36So step two of the STEP trials, again, included approximately like 1200 adults.
- 23:43And this time they chose overweight and obese people with type 2
- 23:49The trial compared semaglutide at 2.4 milligrams, semaglutide at one milligram, so basically like a micro dose and the placebo.
- 23:58So what do we find?
- 23:59Weight loss with the 2.4 milligram dose, the standard dose, was about 9.6% compared to the placebo at 3.4%.
- 24:06So weight loss was actually a little bit lower than in step one, which is causing people with type 2 diabetes.
- 24:12They're going to be...
- 24:14more apt to not lose weight.
- 24:17In this trial, semaglutide at 2.4 milligrams produced an estimated 39% greater reduction in CRP.
- 24:23So we're still seeing that improvement in the C-reactive protein lowering.
- 24:27Yes, I will tie this back to the gut.
- 24:29Bear with me.
- 24:30CRP decreased about, oh gosh, almost 50% from baseline.
- 24:34That is huge.
- 24:35And even in the microdose, this is the important part of step two, even the microdose with semiglutide, we still saw a 42% reduction in inflammation.
- 24:46That was fantastic.
- 24:47Absolutely fantastic.
- 24:49So the anti-inflammatory effect may not require pushing every patient to the maximum dose.
- 24:55This study wasn't designed to determine the lowest dose necessary for reducing inflammation, so we can't really use it as proof of a microdosing protocol.
- 25:03But come on, let's just look at the evidence.
- 25:06If you're getting a 40% to 50% reduction in inflammation with a microdose, you're winning.
- 25:11You're winning.
- 25:12And then in step three of the step trials, we took 611 adults with either they're overweight or obese, did not have diabetes.
- 25:22These participants received more intense behavioral therapy, and they actually changed their diet a little bit.
- 25:29So now we see a little bit of an increase in weight loss up to 16% with semaglutide.
- 25:34It was only 14% in step one, 9% in step two.
- 25:39Now we're up to a 16% average weight loss.
- 25:42And still we're hanging around 48% reduction in CRP.
- 25:45So that was, again, inflammation reduction across the board.
- 25:49Across the board.
- 25:51So what are we seeing with this?
- 25:53We are seeing that full body systemic inflammation reduction across the board, lowering CRP cardiovascular risk.
- 26:00So that's huge as well.
- 26:03And we're seeing it even with the OG medication, with the semaglutide, which honestly what I find in our patient base, we don't...
- 26:13Unless someone specifically asks for semaglutide, we normally use chersapatide because semaglutide really has, you got a 50-50 chance.
- 26:21Yeah.
- 26:22of it actually lowering your weight and affecting your weight and affecting your A1C.
- 26:27It doesn't work in a lot of people.
- 26:29And it comes with a boatload more side effects even at lower doses.
- 26:32So this is where we try to push the terzepatide.
- 26:35However, semaglutide does have a little bit stronger evidence when it comes to inflammation reduction.
- 26:42But you're still going to get that with terzepatide as well.
- 26:47So what is CRP exactly?
- 26:49So CRP stands for C-reactive protein.
- 26:52It's produced by the liver in response to inflammatory signals, especially a signal called cytokine IL-6.
- 26:59You may have heard of that before or talking about inflammation.
- 27:03CRP is not specific to the gut because a high CRP can be associated with obesity or insulin resistance.
- 27:09Infection, we can see it with autoimmune conditions like Hashimoto's, definitely cardiovascular disease or any kind of even tissue injury.
- 27:17If you're injured or other inflammatory conditions, we can see an elevated CRP.
- 27:22So a lower CRP tells us the body's overall inflammatory environment has improved.
- 27:29doesn't really tell us anything about the gut or autoimmune disease or Crohn's or anything like that.
- 27:35But it is an important clue because was the CRP reduction caused simply by weight loss?
- 27:44The answer is partly, but not entirely.
- 27:47The CRP reductions correlated with improvements in body weight
- 27:51waist circumference, obviously waist tightening, fasting glucose went down, insulin went down, insulin resistance actually measured through the HOMAIR measurement, which is even more accurate than fasting insulin, that improves.
- 28:07So this tells us that people who experience greater metabolic improvement generally experience greater reductions in inflammation.
- 28:14And that makes biological sense, doesn't it?
- 28:17That visceral fat that we're losing is not simply stored energy.
- 28:21It literally behaves like an endocrine and an immune organ.
- 28:25So when you have dysfunctional visceral fat, that fat around your organs, the fat that you grab and you're like, I want to get rid of it, but especially the fat around your organs, mainly found in the midsection, that dysfunctional visceral fat can actually release inflammatory signaling molecules.
- 28:40It can increase that IL-6 cytokine.
- 28:43and other cytokines that increase inflammation.
- 28:47It can worsen insulin resistance.
- 28:49It can contribute to fatty liver.
- 28:51So when someone loses that visceral fat and improves insulin sensitivity, it's not.
- 28:57Of course, inflammation is going to decrease.
- 29:00Of course it is.
- 29:01Now, researchers believe that weight loss may not explain the entire CRP reduction.
- 29:06There's more to it.
- 29:08So preclinical research suggests that GLP-1 signaling can affect inflammatory pathways directly.
- 29:16So we're going to reduce that NFKB activity.
- 29:19Oh my gosh, what is that?
- 29:20It's a big long word.
- 29:22NFKB is activated when we're in this massively inflamed state because it literally encourages the production of inflammatory signals.
- 29:32So this is where maybe you've heard of TNF-alpha, IL-1-beta, IL-6.
- 29:38If you haven't, don't worry about it.
- 29:39These are just inflammatory markers that we talk about.
- 29:42When we're talking about full body inflammation, when we're talking about autoimmune conditions, when we're talking about cancer, right?
- 29:48We look at these inflammatory pathways because it ties back to the immune system.
- 29:55And what is cancer?
- 29:56Cancer shows up when our immune system is no longer functioning properly to target those dysfunctional cancer cells, those mutated cells that we all have.
- 30:07This is where improving your immune system and lowering the inflammation can actually help with reduction of cancer.
- 30:13I can't say curing it, but we can say protecting you, protecting you from recurrence of cancer or the occurrence of cancer, not just recurrence, but occurrence.
- 30:25So reducing oxidative stress, as we know, high glucose and high insulin can cause this oxidative stress, can cause inflammation.
- 30:32I mean, really, what is obesity?
- 30:35What is insulin resistance?
- 30:37It's inflammation in the body.
- 30:39I mean, it is oxidative stress in the body.
- 30:41Oxidative stress then activates more inflammation, which worsens insulin resistance, and this creates a vicious cycle.
- 30:48So we can see that this inflammation is tied to the gut.
- 30:53It's tied to our immune system.
- 30:54It's tied to how we feel.
- 30:56So by improving this glucose regulation and potentially affecting cellular signaling, GLP-1 medications may interrupt that cycle and literally decrease oxidative stress, protect us against cancer, break that insulin resistance oxidative stress cycle, which just keeps going in a circle, sets us up for more cancer and obviously more obesity.
- 31:17So what can we conclude from this?
- 31:20We know that semaglutide has demonstrated a meaningful reduction in systemic inflammation in these large randomized trials.
- 31:30We can also say that part of that reduction is likely due to weight loss, reduced visceral fat, and improved insulin resistance, but direct anti-inflammatory signaling may contribute.
- 31:41But we cannot necessarily say from the step trials that there's healing of the gut.
- 31:48We can just extrapolate the information and tie it together, the inflammation information, tie all that together and come up with our analysis of it.
- 31:57So now let's get into can GLP-1 strengthen the intestinal barrier?
- 32:01Okay, what's the intestinal barrier?
- 32:03The intestinal barrier is not simply the wall of the intestine.
- 32:06It actually includes a layer of epithelial cells, tight junctions that are holding those cells together, then a protective mucus layer.
- 32:17There's immune cells in there.
- 32:19There's antimicrobial compounds.
- 32:22And then there's the microbiome that you hear us talk about all the time.
- 32:26So its job, the intestinal barrier's job, is to absorb nutrients while controlling what is allowed to move from the intestine into the bloodstream.
- 32:37We need some permeability, otherwise we couldn't absorb nutrients.
- 32:41The problem is leaky gut or excessive permeability.
- 32:46So this is why we're talking about leaky gut.
- 32:49This is what people mean when they say leaky gut.
- 32:51When the barrier is disrupted, substances from inside the gut may cross over more easily.
- 32:58So these can include bacterial fragments.
- 33:00You might hear the term lipopolysaccharide or LPS.
- 33:04It's basically garbage.
- 33:06It's garbage entering your bloodstream by pushing through that intestinal lining because you have leaky gut.
- 33:14And all of this extra garbage going into your body, of course, is going to stimulate immune receptors.
- 33:20It's going to promote inflammation.
- 33:22It's going to cause fatty liver.
- 33:24It's going to cause more obesity and insulin resistance, a huge feedback loop.
- 33:29And then if you throw on poor diet on top of that,
- 33:32Again, low thyroid function, metabolic dysfunction.
- 33:37You're going to get this intestinal barrier dysregulation, more inflammation, inflammation versus insulin resistance, insulin resistance further damages metabolic and intestinal health.
- 33:47And it's one big nasty loop, nasty loop.
- 33:51So how will this GLP-1 signaling help?
- 33:54So what we're seeing is that GLP-1s have been associated with in these studies
- 34:00of improved tight junction proteins, which will help to reduce the permeability, the leakiness of your gut, reduced excessive intestinal permeability, exactly what I just said, less death of intestinal crypt cells.
- 34:18Now we'll get to that.
- 34:18Crypts are small structures in the intestinal lining where new
- 34:22intestinal cells are generated.
- 34:23So protecting crypt cells may help the intestine replace the damaged epithelial cells and basically maintain its barrier.
- 34:33We're also seeing reduced inflammation, improved mucosal repair, less movement of bacterial products, garbage across the barrier.
- 34:41So that's fantastic.
- 34:43Now, a lot of this has not been proven in humans.
- 34:47The studies establish the biological plausibility of this happening, meaningful intestinal permeability problem.
- 34:55Human randomized trials specifically measuring intestinal permeability are just now emerging.
- 35:04So we can say the GLP-1s appear to protect the intestinal barrier in animal and laboratory studies.
- 35:12Whether SEMA, Archer's Epitaphine produces meaningful gut barrier repair in humans, still not determined.
- 35:18So we can't say GLP-1s cure leaky gut, but we're seeing a lot of improvements and we're seeing a lot of anecdotal data, which honestly, I love anecdotal data almost more than the RTC trials.
- 35:32So observational studies.
- 35:34Observational studies are showing, like I said in the beginning, the GLP-1 medications don't worsen IBD.
- 35:41They actually help.
- 35:43Fewer IBD-related surgeries, fewer hospitalizations, a decrease in steroid prescriptions, which is huge because steroids are just a mean, mean drug.
- 35:54So if we can reduce that in anyone, oh my gosh, yes, all day long, yes.
- 36:01Now, there was a 2025 systemic review, including 11 studies and more than 16,000 patients with IBD.
- 36:08And GLP-1 use was associated with lower risks of surgery and hospitalization, especially in the patients that,
- 36:16also had obesity.
- 36:18And we're seeing that this study suggests that reducing visceral fat, reducing that insulin resistance, reducing obesity-related inflammatory signaling takes the pressure off of the inflammatory bowel disease, off of IBD.
- 36:34Now, is it directly treating Crohn's disease or alternative colitis?
- 36:40It doesn't prove that, but we just don't know.
- 36:43We might see that down the line as more and more studies, as more and more people have this anecdotal experience, we're also going to see more and more studies come out with the human trials with IBD and intestinal permeability.
- 36:58Now, I talked about acromantia earlier on.
- 37:01This deserves more explanation because acromantia is really becoming another health buzzword.
- 37:06So what is it?
- 37:07So first of all, it's a bacteria that lives primarily in the mucus layer covering the intestinal wall.
- 37:14And acromantia, it just, it does so much in our gut.
- 37:18It does so much in our gut.
- 37:20So what do we say?
- 37:22Acromantia will actually increase the bacteria that we want in our gut, which provides protection of that mucus layer.
- 37:32Okay.
- 37:33So in a healthy system, we want to control that mucus layer and stimulate mucus turnover.
- 37:41Believe it or not, we want it to kind of break down and turn over and clear, break down, turn over and clear.
- 37:47That happens in a healthy system.
- 37:49Acromantia breaks down the old mucon layer, like the garbage layer that we want to break down and clear.
- 37:55And then that interaction may signal your body to produce more mucus, like good.
- 38:01So we clear the bad, produce the good, clear the bad, produce the good.
- 38:04It just maintains the healthy cycle.
- 38:07in your gut.
- 38:08So that mucus layer creates the physical distance between the gut bacteria and the intestinal cells.
- 38:15So it's preventing bacteria from directly contacting your intestinal wall.
- 38:20It's protecting the epithelial cells.
- 38:22It's regulating your immune exposure.
- 38:24Here we have that, again, cancer protection layer, maintaining intestinal barrier, maintaining
- 38:30integrity.
- 38:31I mean, it's just, and it's providing a beautiful habitat for beneficial gut bacteria.
- 38:36We always want the beneficial.
- 38:38We don't want the bad.
- 38:38We want the good.
- 38:40So if that mucus layer becomes too thin or becomes dysfunctional, then bacteria and bacterial products may interact more directly with the intestinal lining and the immune system.
- 38:50Now, what are the other possible benefits of acromantia?
- 38:55And I know there's a lot of products out there that claim to increase your acromantia naturally, but I got to tell you, everything that I've seen shows that it doesn't really, it doesn't nail it.
- 39:07Those products seem to be more of a waste of money and time.
- 39:11I think you're actually better going with a GLP-1 or GLP.
- 39:16I keep saying GLP-1, but it's GLP because of everything that we're seeing with GLPs and the gut.
- 39:23So we're improving this gut microbiome.
- 39:26We're strengthening up the barrier.
- 39:29We're improving our immune system.
- 39:31Yeah.
- 39:32And then we are lowering that inflammation in our gut, which might be one of the reasons why I noticed the decrease in my bloating.
- 39:40Because if I'm taking a GLP-1, and yes, it was very, very fast.
- 39:44It was fast acting.
- 39:45But if I'm taking it and I immediately start producing the good bacteria, then naturally that bloat is going to go down because it really does create this healthy microbiome environment.
- 39:58Right.
- 39:59The GLP-1 studies, so there was a 2025 systematic review examining 38 animal and human studies of GLP-1 medications, the microbiome.
- 40:09What are we finding?
- 40:10That GLP-1 therapies can change the microbial richness, the microbial diversity, everything that we're talking about.
- 40:18We're just improving your microbiome, which helps with digestion, which helps with bloating, which helps with the signaling of the gut.
- 40:27to all of the other places like we talked about, the brain, the pancreas, everything.
- 40:32Now, it always comes back to this.
- 40:35If you're eating garbage and you expect to get a result, it's not going to work.
- 40:42I'm sorry.
- 40:43A GLP-1 is not going to put out a dumpster fire in your body.
- 40:49If you're treating your body like a circus and you're putting in garbage in, garbage in, garbage in, a little GLP-1 medication isn't going to override that at all.
- 40:59But when it's done properly with the proper diet, that's where we see the benefits.
- 41:03So what about bile acid diarrhea, IBS?
- 41:08Why slowing the gut can help or harm?
- 41:10Okay, so the liver produces bile acids.
- 41:12Bile acids are stored in the gallbladder and released into the small intestine when we eat.
- 41:18especially when we eat fat.
- 41:20So their primary job is to help break down and absorb dietary fat.
- 41:25After doing their job, about 95% of bile acids are normally reabsorbed near the end of the small intestine and returned to the liver.
- 41:33The body basically recycles them.
- 41:36So what is this bile acid diarrhea?
- 41:38So in some people, too many bile acids escape reabsorption.
- 41:42They enter the colon.
- 41:43And the colon is the final larger section of the intestine where water is absorbed, stool is formed.
- 41:49So when excessive bile acids reach the colon,
- 41:52They can draw water into the bowel.
- 41:55They can stimulate intestinal secretion.
- 41:57They can increase that urgency and motility.
- 41:59You gotta go.
- 42:01Or frequent watery stools can be the end product.
- 42:05This is called bile acid diarrhea.
- 42:07Do you have it?
- 42:10So symptoms may include frequent watery diarrhea, sudden urgency, difficulty controlling your bowel movements, cramping, bloating, symptoms after high-fat meals.
- 42:21Bile acid diarrhea can occur after gallbladder removal or...
- 42:26a disease involving the end of the small intestine, but can also occur without an obvious structural cause.
- 42:33Some people just have it.
- 42:34Some people diagnosed with IBD may have bile acid diarrhea.
- 42:39So you might have been improperly diagnosed with IBD or IBSD, but you actually have bile acid diarrhea.
- 42:48So what do we find?
- 42:50We found that using the OOGs, the liraglutide GLPs, in a double-blind trial with 52 adults, confirmed moderate to severe bile acid diarrhea, they all had it,
- 43:03And what did we see?
- 43:05We saw a 25% reduction in that bile acid diarrhea, 25% reduction in daily stool frequency.
- 43:12I mean, that's huge.
- 43:13Six of the 26 Liraglutine participants reported mild nausea, which we see in those OGs and OOG medications, GLPs, but we were still seeing a reduction in diarrhea.
- 43:27That is huge.
- 43:28That's huge.
- 43:30In the ROSE 10 research experiment, they used a short-acting GLP-1 receptor, studied for acute IBS pain.
- 43:41And what did we find?
- 43:43Benefits, benefits, benefits.
- 43:45Gut-brain signaling improved.
- 43:47Increased sensitivity to normal intestinal movement improved.
- 43:52Less diarrhea, that improved.
- 43:55So...
- 43:56What we're seeing overall with these studies is that there's an improvement in your gut.
- 44:04If you go overboard with your dosing, you will get symptoms.
- 44:10You're going to get GI symptoms.
- 44:12You're going to get too much of your slowdown.
- 44:14You're going to get the constipation.
- 44:16You're going to get the bloating.
- 44:18You're going to get the nausea and the vomiting, not the diarrhea, because you're going to get slowed down.
- 44:23And yeah, you could get gastroparesis or severe chronic constipation, bowel obstruction, gall bladder symptoms, all of it.
- 44:32But if you use it properly, if you use it properly in the right dose, this is where we are seeing the anti-inflammatory effect.
- 44:43We're seeing the improvement in gut inflammation.
- 44:46We're seeing improvement in distention, bloating.
- 44:49We're seeing an improvement across the board.
- 44:52with the gut and these GLP-1s.
- 44:55I'm not going to tell you that a GLP-1 is going to heal every single gut, but I'm not going to pretend like they do nothing other than suppress your appetite.
- 45:03No, these are powerful metabolic, digestive, and inflammatory signaling tools.
- 45:09And the answer is to not fear them or to worship them
- 45:15like people on YouTube did.
- 45:17Go check them out.
- 45:18Go check out the comments.
- 45:20The answer is to use them intelligently.
- 45:22The right person, the right dose, the right reason, while protecting muscle and nutrition, while monitoring your digestive function.
- 45:29Let's monitor it.
- 45:30Let's not just alter it.
- 45:32Let's actually say, how you doing?
- 45:35Are you having the poops?
- 45:36Or are you constipated?
- 45:38Let's figure this out.
- 45:39And while correcting the underlying thyroid hormone and metabolic problems,
- 45:44the GLP-1s cannot fix for you.
- 45:46Because again, if you listened to a previous episode, GLP-1s don't increase your metabolism.
- 45:51They don't.
- 45:52Because losing weight while sacrificing muscle nutrition and gastrointestinal function is not health optimization.
- 45:58Doing things properly at the right dose for you is.
- 46:03So I hope this helps you better understand the benefits.
- 46:07Yeah, I talked about benefits.
- 46:09Benefits of GLP ones.
- 46:11Like I said, I have no dog in this race.
- 46:13I only want to help you and give you the information that you need to stay healthy, to stay optimized, and to live your best life.
- 46:20Be the badass human that you're meant to be.